
Comprehensive overview of COVID-19 research by Dr Philip McMillan, focusing on autoimmunity as the primary pathology in the disease.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 694 | Founded | 5 years ago | Last Issue | 5 days ago |
| Active | |||||

Another promising cardiovascular drug has failed at the point that matters most: preventing heart attacks, strokes and cardiovascular death.
Pelacarsen was designed to lower lipoprotein(a), or Lp(a), a genetically determined particle assoc...
For years, the public discussion of COVID vaccine associated myocarditis has been framed in reassuring language. Rare. Generally mild. Benefits outweighing risks, including for adolescents and young adults.
A newly published analysis of an...
Canada is doing something important.
Between 8 and 11 September 2026, the Allison Inquiry is listening to Canadians who believe COVID-19 vaccination injured them. Chaired by Member of Parliament Dean Allison, the hearings are broadcast fro...
The most important person in a pharmaceutical company may be the one willing to say no (timecodes below).
That is what I took from my latest conversation with Susan F. Langlois, a retired vaccine-industry regulatory affairs specialist with...
I have been thinking about a story from March 2026. An Army doctor is now examining military deaths that followed COVID vaccination.
Start with the simplest test. In a young, fit soldier with no known history, screened before enlistment, e...
Subscribers, engagement, traffic and sponsorship for Vejon COVID-19 Review.
| Subscribers | Engagement | 83 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #54 | |
| #36 |
The writers behind this newsletter.
Physician and researcher with an innovative approach to COVID-19 and dementia reversal, international keynote speaker and LinkedIn Live influencer.
You can find recent issues that have been published by Vejon COVID-19 Review on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Vejon COVID-19 Review, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Vejon COVID-19 Review as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Vejon COVID-19 Review using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Vejon COVID-19 Review. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.